Research and development
2025Fiscal year
Companies 81
Median of average pay per employee · KRW 61 million
Median of average pay per registered director · KRW 190 million
| Company | Average pay per employee sorted descending | Average pay per registered director sort by this column | Reported persons covered sort by this column | Employees sort by this column | Notes |
|---|---|---|---|---|---|
| 에이프릴바이오 | KRW 360 million | KRW 282 million | 2 | 12 | |
| CG인바이츠 | KRW 60 million | KRW 54 million | 6 | 92 | |
| 휴코드홀딩스 | Value not displayed | Value not displayed | 3 | — | |
| 알지노믹스 | KRW 193 million | KRW 221 million | 6 | 39 | Denominator mismatch flagged |
| 올릭스 | KRW 186 million | KRW 759 million | 5 | 76 | |
| 디앤디파마텍 | KRW 169 million | KRW 260 million | 3 | 22 | |
| 리가켐바이오 | KRW 157 million | KRW 194 million | 5 | 180 | |
| 바이젠셀 | KRW 155 million | KRW 197 million | 3 | 43 | |
| 알테오젠 | KRW 149 million | KRW 862 million | 4 | 161 | |
| 지아이이노베이션 | KRW 143 million | KRW 555 million | 4 | 42 | Denominator mismatch flagged |
| 큐리언트 | KRW 139 million | KRW 190 million | 6 | 32 | |
| 에스케이바이오팜 | KRW 121 million | KRW 663 million | 3 | 272 | Filer note attached |
| 이뮨온시아 | KRW 115 million | KRW 344 million | 2 | 22 | |
| 네오이뮨텍 | KRW 114 million | KRW 244 million | 1 | 40 | Filer note attached · Denominator mismatch flagged |
| 보로노이 | KRW 104 million | KRW 137 million | 3 | 72 | |
| 페니트리움바이오 | KRW 97 million | KRW 94 million | 6 | 29 | |
| 프로젠 | KRW 91 million | KRW 42 million | 5 | 15 | |
| CJ 바이오사이언스 | KRW 88 million | KRW 312 million | 2 | 50 | Filer note attached |
| 툴젠 | KRW 85 million | KRW 188 million | 6 | 66 | |
| 큐라클 | KRW 84 million | KRW 198 million | 4 | 31 | |
| 바이오인프라생명과학 | KRW 84 million | KRW 78 million | 2 | 3 | |
| 제넥신 | KRW 83 million | KRW 215 million | 3 | 68 | |
| 프로티나 | KRW 79 million | KRW 110 million | 7 | 28 | Filer note attached |
| 온코닉테라퓨틱스 | KRW 79 million | KRW 447 million | 2 | 14 | |
| 인벤테라 | KRW 78 million | KRW 342 million | 2 | 18 | |
| 아리바이오LAB | KRW 77 million | KRW 73 million | 3 | 14 | |
| 신라젠 | KRW 76 million | KRW 178 million | 2 | 56 | |
| 카이노스메드 | KRW 74 million | KRW 164 million | 2 | 15 | |
| 지니너스 | KRW 72 million | KRW 100 million | 1 | 59 | |
| 플럼라인생명과학 | KRW 71 million | KRW 128 million | 3 | 5 | Denominator mismatch flagged |
| 압타바이오 | KRW 70 million | KRW 328 million | 3 | 45 | |
| 싸이토젠 | KRW 70 million | KRW 129 million | 5 | 39 | |
| 아퓨어스 | KRW 69 million | KRW 98 million | 3 | 12 | |
| 큐라티스 | KRW 66 million | KRW 31 million | 4 | 26 | Denominator mismatch flagged |
| 메지온 | KRW 64 million | KRW 145 million | 4 | 18 | |
| 쓰리빌리언 | KRW 63 million | KRW 250 million | 3 | 98 | |
| 아이엠바이오로직스 | KRW 63 million | KRW 159 million | 4 | 41 | |
| 에임드바이오 | KRW 63 million | KRW 226 million | 3 | 52 | |
| 파로스아이바이오 | KRW 62 million | KRW 212 million | 3 | 33 | |
| HLB바이오스텝 | KRW 62 million | KRW 416 million | 4 | 150 | Denominator mismatch flagged |
| 인벤티지랩 | KRW 61 million | KRW 266 million | 5 | 73 | |
| 온코크로스 | KRW 61 million | KRW 260 million | 3 | 40 | |
| HLB제약 | KRW 60 million | KRW 132 million | 4 | 93 | |
| 와이바이오로직스 | KRW 60 million | KRW 294 million | 3 | 58 | |
| 바이오인프라 | KRW 59 million | KRW 190 million | 3 | 141 | |
| 아이진 | KRW 59 million | KRW 127 million | 4 | 49 | |
| 랩지노믹스 | KRW 58 million | KRW 88 million | 3 | 142 | |
| 고바이오랩 | KRW 58 million | KRW 219 million | 3 | 57 | Filer note attached |
| 메드팩토 | KRW 58 million | KRW 175 million | 4 | 54 | |
| 티움바이오 | KRW 58 million | KRW 267 million | 3 | 67 | |
| HEM파마 | KRW 55 million | KRW 103 million | 7 | 101 | Filer note attached |
| 카나프테라퓨틱스 | KRW 55 million | KRW 203 million | 3 | 23 | |
| 드림씨아이에스 | KRW 55 million | KRW 179 million | 4 | 395 | Filer note attached |
| 셀리드 | KRW 55 million | KRW 153 million | 3 | 24 | Filer note attached · Denominator mismatch flagged |
| 엔솔바이오사이언스 | KRW 55 million | KRW 132 million | 6 | 28 | |
| 박셀바이오 | KRW 55 million | KRW 212 million | 2 | 91 | |
| 에이비온 | KRW 55 million | KRW 189 million | 4 | 34 | Filer note attached |
| 큐로셀 | KRW 55 million | KRW 257 million | 3 | 146 | |
| 헬릭스미스 | KRW 54 million | KRW 182 million | 5 | 44 | |
| 츌립앤사이언스 | KRW 54 million | KRW 360 million | 6 | 44 | |
| 프레스티지바이오파마 | KRW 53 million | KRW 541 million | 3 | 67 | Filer note attached · Fiscal year end 06 |
| 지노믹트리 | KRW 52 million | KRW 288 million | 2 | 76 | |
| 무진메디 | KRW 51 million | KRW 70 million | 3 | 16 | |
| 아이엠비디엑스 | KRW 50 million | KRW 193 million | 4 | 65 | |
| 내츄럴엔도텍 | KRW 50 million | KRW 44 million | 4 | 83 | |
| 안지오랩 | KRW 49 million | KRW 120 million | 3 | 15 | |
| 인바이츠바이오코아 | KRW 49 million | KRW 117 million | 4 | 133 | |
| 크로넥스 | KRW 49 million | KRW 85 million | 4 | 26 | |
| 오가노이드사이언스 | KRW 48 million | KRW 112 million | 6 | 89 | |
| 퓨쳐메디신 | KRW 47 million | KRW 81 million | 2 | 4 | |
| 디티앤씨알오 | KRW 47 million | KRW 246 million | 2 | 314 | |
| 바이오톡스텍 | KRW 47 million | KRW 285 million | 3 | 241 | |
| 에피바이오텍 | KRW 47 million | KRW 124 million | 2 | 23 | |
| 콜마바이오텍 | KRW 47 million | KRW 130 million | 4 | 127 | |
| 노브메타파마 | KRW 46 million | KRW 134 million | 7 | 21 | |
| 진매트릭스 | KRW 45 million | KRW 360 million | 3 | 69 | |
| 모아라이프플러스 | KRW 45 million | KRW 180 million | 4 | 32 | |
| 제이에스링크 | KRW 44 million | KRW 191 million | 6 | 139 | |
| EDGC | KRW 44 million | KRW 112 million | 2 | 63 | |
| 메디젠휴먼케어 | KRW 34 million | KRW 83 million | 2 | 13 | |
| 인투셀 | Value not displayed | KRW 204 million | 3 | — |
The reported persons covered can differ from the denominator behind the amount.
Before reading this table
- Figures collect the filed per-person averages without transformation, and can differ from totals divided by headcounts.
- Listed filers only, and consolidated subsidiaries' staff are not included.
- These are filed values whose accuracy the source institution does not guarantee.
- Company rows reproduce each filer's own reported values without transformation, and this site computes none of them.
- Where few registered directors are covered, the per-person average approaches a few individuals' pay.
- Sharing an industry code does not mean doing the same work.
- Filed values needing a unit check show the reason instead of an amount.
- Classifications with thin samples publish no industry figure.
Industry groupings and names follow the tenth revision of the Korean Standard Industrial Classification, opened by Statistics Korea under the Korea Open Government Licence attribution requirement, with minor typographic adjustments.